ESR1 and neoplasm: Such alterations may shift the balance between estrogen receptor alfa and beta (ERα and Erβ) signaling within the prostatic microenvironment, favoring ERα-associated proliferative and inflammatory responses while attenuating ERβ-mediated tumor-suppressive effects [92,93].